AD, predicted to affect more than 152 million people by 2050, is now recognized as common senile dementia with main pathological hallmarks, such as extracellular neuritic plaques containing amyloid-β peptide (Aβ) and intracellular neurofibrillary tangles composed of hyper phosphorylated tau [7]. This evidence concerns the gene MAPT and Alzheimer disease.